Jane Street Group, LLC Genfit S.A. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$10.95 - $20.76 $177,740 - $336,976	-16,232 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.55 - $20.14 $211,962 - $315,050	-15,643 Reduced 49.08%	16,232 $321,000
Q3 2019 Nov 14, 2019	BUY	$14.92 - $19.94 $211,401 - $282,529	14,169 Added 80.02%	31,875 $511,000
Q2 2019 Aug 15, 2019	SELL	$19.74 - $25.65 $610,222 - $792,918	-30,913 Reduced 63.58%	17,706 $355,000
Q1 2019 May 16, 2019	BUY	$22.17 - $24.0 $1.08 Million - $1.17 Million	48,619 New	48,619 $1.17 Million

49.2K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $252M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.